Rinvoq ER 15 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F9U26
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $72,804
Award facts
- Contract value 100% obligated
- $72,804.46 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $72,804.46 firm fixed-price delivery order to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count units) with an ultimate completion date of January 5, 2026. This competitively awarded, non-set-aside contract is classified as a child award, indicating it is issued under a larger indefinite delivery contract vehicle. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement and has been designated as a prime vendor for the Defense Logistics Agency's pharmaceutical supply chain supporting military and veteran healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This comprehensive pharmaceutical support vehicle enables the company to supply a wide range of medications, vaccines, and medical supplies to support military healthcare programs globally. The current delivery order for RINVOQ, a specialty pharmaceutical product, reflects the company's role in fulfilling critical medication needs across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through flexible contract mechanisms designed to ensure consistent access to pharmaceutical products.
Quick answers
Who was awarded contract SPE2DR26F9U26?
SPE2DR26F9U26 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 2, 2026.
How much is contract SPE2DR26F9U26 worth?
The government has obligated $72,804 on SPE2DR26F9U26.
Is contract SPE2DR26F9U26 an order under another contract?
Yes. SPE2DR26F9U26 is a delivery order under SPE2DR25D3103, an indefinite delivery contract.
Was contract SPE2DR26F9U26 competed?
The extent of competition for SPE2DR26F9U26 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award